Physician profile
Florian Huber
NPI 1144487760
$12,264.34
in general payments reported to CMS, 2019-2025
7 companies · $3,744 in 2025
The $3,744 reported for 2025 was more than what a typical Orthopaedic Trauma provider received nationally (typical 2025 total: $1,227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,526 · 2022: $111 · 2023: $4,772 · 2024: $111 · 2025: $3,744.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,464 · Food and Beverage: $2,163 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,500 · Consulting Fee: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,463.90 |
| Food and Beverage | $2,163.27 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,500.00 |
| Consulting Fee | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Synthes Gmbh | $8,690.85 | 2019-2025 | |
| Smith+Nephew, INC. | $3,049.75 | 2022-2025 | Evos, Trigen, Trigen Intertan |
| Depuy Synthes Sales INC. | $219.32 | 2019-2022 | |
| Stryker Corporation | $154.95 | 2019 | |
| Abbott Laboratories | $99.50 | 2019 | |
| Supreme Orthopedic Systems, LLC | $32.98 | 2024 | |
| Silk Road Medical, INC. | $16.99 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Florian Huber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.